METTL3 expression was found to be upregulated in lung cancer, breast cancer, liver cancer and glioblastoma (47–50) and associated with metastasis in lung cancer (47) and oral squamous cell carcinoma (51). Here, METTL3 is linked to oral cavity squamous cell carcinoma.